L'Institut national américain des normes et de la 21-02-2023, 13:24

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51

European Commission approves label expansion of Roche’s 1-02-2023, 13:17